High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$510K
$510,342
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TVTX
S
Travere Therapeutics, Inc.
Heerma Peter
• Officer • CHIEF COMMERCIAL OFFICER
Sell to Cover
2026-02-03
$234,797
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
Officer • CHIEF COMMERCIAL OFFICER
Sell to Cover
|
2026-02-03 | $234,797 | S | Form 4 |
|
TVTX
S
Travere Therapeutics, Inc.
Heerma Peter
• Officer • CHIEF COMMERCIAL OFFICER
10b5-1 Sell
2025-10-31
$195,685
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
Officer • CHIEF COMMERCIAL OFFICER
10b5-1 Sell
|
2025-10-31 | $195,685 | S | Form 4 |
|
TVTX
S
Travere Therapeutics, Inc.
Heerma Peter
• Officer • CHIEF COMMERCIAL OFFICER
10b5-1 Sell
2025-10-28
$79,860
|
||||||
| TVTX |
Travere Therapeutics, Inc.
|
Officer • CHIEF COMMERCIAL OFFICER
10b5-1 Sell
|
2025-10-28 | $79,860 | S | Form 4 |